The addition of an antistaphylococcal beta-lactam to standard antibiotic therapy did not result in significant improvement for patients hospitalized with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, an international team of researchers reported in JAMA.
With cases of the novel coronavirus (COVID-19) increasing across the globe, why should we be paying attention to influenza — a respiratory illness that is seen year after year? The answer lies in the numbers. Currently, there have been 13[…]
A new group of antibiotics with a unique approach to attacking bacteria has been discovered, making it a promising clinical candidate in the fight against antimicrobial resistance.The newly found corbomycin and the lesser-known complestatin have a never-before-seen way to kill[…]